Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZC89
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,449.30 to DMS Pharmaceutical Group Inc. for the supply of Entyvio 300 mg vials, with performance in Park Ridge, Illinois and completion targeted for October 20, 2025. This firm fixed-price delivery order was issued without set-aside designation on September 26, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and will fulfill this pharmaceutical delivery directly to military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $500 million and valid through November 2026. The underlying contract enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support Department of Defense healthcare operations worldwide. Entyvio (vedolizumab), a biologic therapeutic, represents one of many specialty pharmaceutical products the contractor supplies to federal military health facilities through this strategic supply agreement.
Quick answers
Who was awarded contract SPE2DB25FZC89?
SPE2DB25FZC89 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FZC89 worth?
The government has obligated $49,449 on SPE2DB25FZC89.
Is contract SPE2DB25FZC89 an order under another contract?
Yes. SPE2DB25FZC89 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC89 competed?
The extent of competition for SPE2DB25FZC89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award